BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, January 16, 2026
Home
»
Authors
» Aaron Lorenzo
Aaron Lorenzo
Articles
ARTICLES
Miikana Comes Together As An Oncology Drug Developer
Oct. 8, 2003
By
Aaron Lorenzo
Flamel Raises $62M Through Sale Of Its Common Shares
Oct. 8, 2003
By
Aaron Lorenzo
Ingenium Broadens Relationship With Elan For Target Validation
Oct. 7, 2003
By
Aaron Lorenzo
Ingenium Broadens Relationship With Elan For Target Validation
Oct. 7, 2003
By
Aaron Lorenzo
Flamel Raises $62M Through Sale Of Its Common Shares
Oct. 6, 2003
By
Aaron Lorenzo
Ariad Gets $41M In Private Sale For Drug Development
Oct. 6, 2003
By
Aaron Lorenzo
Ariad Gets $41M In Private Sale For Drug Development
Oct. 6, 2003
By
Aaron Lorenzo
Flamel Raises $62M Through Sale Of Its Common Shares
Oct. 6, 2003
By
Aaron Lorenzo
Biosyn Eyeing $10M For HIV Product Development Program
Oct. 3, 2003
By
Aaron Lorenzo
Biosyn Eyeing $10M For HIV Product Development Program
Oct. 3, 2003
By
Aaron Lorenzo
View All Articles by Aaron Lorenzo
